Journal of the American Society of Echocardiography
Volume 22, Issue 11 , Pages 1239-1245 , November 2009

Prognostic Value of Ventricular-Arterial Coupling and B-Type Natriuretic Peptide in Patients After Myocardial Infarction: A Five-Year Follow-Up Study

  • Francesco Antonini-Canterin, MD

      Affiliations

    • Cardiologia, ARC, Azienda Ospedaliera “S Maria Degli Angeli”, Pordenone, Italy
    • Corresponding Author InformationReprint requests: Francesco Antonini-Canterin, MD, Cardiologia, ARC, Azienda Ospedaliera “S Maria Degli Angeli”, Via Montereale, 24, 33170 Pordenone, Italy
    • ,
  • Roxana Enache, MD

      Affiliations

    • “Prof Dr C. C. Iliescu” Institute of Cardiovascular Diseases, Bucharest, Romania
    • ,
  • Bogdan Alexandru Popescu, MD, PhD, FESC

      Affiliations

    • “Prof Dr C. C. Iliescu” Institute of Cardiovascular Diseases, Bucharest, Romania
    • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
    • ,
  • Andreea Catarina Popescu, MD, PhD, FESC

      Affiliations

    • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
    • Department of Cardiology, Elias Hospital, Bucharest, Romania
    • ,
  • Carmen Ginghina, MD, PhD, FESC, FACC

      Affiliations

    • “Prof Dr C. C. Iliescu” Institute of Cardiovascular Diseases, Bucharest, Romania
    • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
    • ,
  • Elisa Leiballi, MD

      Affiliations

    • Cardiologia, ARC, Azienda Ospedaliera “S Maria Degli Angeli”, Pordenone, Italy
    • ,
  • Rita Piazza, MD

      Affiliations

    • Cardiologia, ARC, Azienda Ospedaliera “S Maria Degli Angeli”, Pordenone, Italy
    • ,
  • Daniela Pavan, MD

      Affiliations

    • Cardiologia, ARC, Azienda Ospedaliera “S Maria Degli Angeli”, Pordenone, Italy
    • ,
  • Daniela Rubin, MD

      Affiliations

    • Chimica Clinica, Azienda Ospedaliera “S Maria Degli Angeli”, Pordenone, Italy
    • ,
  • Piero Cappelletti, MD

      Affiliations

    • Chimica Clinica, Azienda Ospedaliera “S Maria Degli Angeli”, Pordenone, Italy
    • ,
  • Gian Luigi Nicolosi, MD, FESC, FACC

      Affiliations

    • Cardiologia, ARC, Azienda Ospedaliera “S Maria Degli Angeli”, Pordenone, Italy

References 

  1. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15
  2. Laurent S, Katsahian S, Fassot C, Tropeano AI, Laloux B, Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203–1206
  3. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation. 2002;106:2085–2090
  4. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439
  5. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, et al. Health ABC Study. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005;111:3384–3390
  6. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113:664–670
  7. Chen CH, Nakayama M, Nevo E, Fetics BJ, Maughan WL, Kass DA. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol. 1998;32:1221–1227
  8. Kass DA, Maughan WL. From “Emax” to pressure-volume relations: a broader view. Circulation. 1988;77:1203–1212
  9. Frenneaux M, Williams L. Ventricular-arterial and ventricular-ventricular interactions and their relevance to diastolic filling. Prog Cardiovasc Dis. 2007;49:252–262
  10. Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation. 1992;86:513–521
  11. Kass DA. Ventricular arterial stiffening. Integrating the pathophysiology. Hypertension. 2005;46:185–193
  12. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation. 2003;107:714–720
  13. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014–1021
  14. James SK, Lindbäck J, Tilly J, Siegbahn A, Venge P, Armstrong P, et al. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. J Am Coll Cardiol. 2006;48:1146–1154
  15. Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, et al. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J Am Coll Cardiol. 2008;51:1188–1195
  16. Lindahl B, Lindbäck J, Jernberg T, Johnston N, Stridsberg M, Venge P, et al. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes: a Fragmin and Fast Revascularisation During Instability in Coronary Artery Disease (FRISC)-II substudy. J Am Coll Cardiol. 2005;45:533–541
  17. Tapanainen JM, Lindgren KS, Mäkikallio TH, Vuolteenaho O, Leppäluoto J, Huikuri HV. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2004;43:757–763
  18. Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, et al. Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide. The LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol. 2008;51:1857–1864
  19. Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, et al. Christchurch Cardioendocrine Research Group and the Australia-New Zealand Heart Failure Group Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol. 2006;47:52–60
  20. Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, et al. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina. Results from the AtheroGene Study. J Am Coll Cardiol. 2006;47:552–558
  21. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357–2368
  22. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367
  23. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458
  24. Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol. 1999;84:829–832
  25. Schwammenthal E, Popescu BA, Popescu AC, Di Segni E, Kaplinsky E, Rabinowitz B, et al. Noninvasive assessment of left ventricular end-diastolic pressure by the response of the transmitral a-wave velocity to a standardized Valsalva maneuver. Am J Cardiol. 2000;86:169–174
  26. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194–202
  27. Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PYA, et al. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol. 2001;38:2028–2034
  28. Kass DA. Age-related changes in ventricular-arterial coupling: pathophysiologic implications. Heart Fail Rev. 2002;7:51–62
  29. Prabhu SD. Altered left ventricular-arterial coupling precedes pump dysfunction in early heart failure. Heart Vessels. 2007;22:170–177
  30. Mehra MR, Milani RV, Richie MB, Uber PA, Park MH, Ventura HO, et al. Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation. Transpl Proc. 2004;36:3149–3151
  31. Milani RV, Mehra MR, Lavie CJ, Ventura HO. Comparison of cardiac and peripheral arterial stiffening and ventriculovascular uncoupling in patients with uncomplicated hypertension versus patients with hypertension after heart transplantation. Am J Cardiol. 2006;98:789–792
  32. Barclay JL, Kruszewski K, Croal BL, Cuthbertson BH, Oh JK, Hillis GS. Relation of left atrial volume to B-type natriuretic peptide levels in patients with stable chronic heart failure. Am J Cardiol. 2006;98:98–101
  33. Popescu BA, Popescu AC, Antonini-Canterin F, Rubin D, Cappelletti P, Piazza R, et al. Prognostic role of left atrial volume in elderly patients with symptomatic stable chronic heart failure: comparison with left ventricular diastolic dysfunction and B-type natriuretic peptide. Echocardiography. 2007;24:1035–1043
  34. Dawson A, Davies JI, Morris AD, Struthers AD. B-type natriuretic peptide is associated with both augmentation index and left ventricular mass in diabetic patients without heart failure. Am J Hypertens. 2005;18:1586–1591
  35. Sakuragi S, Okawa K, Iwasaki J, Tokunaga N, Kakishita M, Ohe T. Aortic stiffness is an independent determinant of B-type natriuretic peptide in patients with coronary artery disease. Cardiology. 2007;107:140–146
  36. Yambe M, Tomiyama H, Koji Y, Motobe K, Shiina K, Gulnisia Z, et al. B-type natriuretic peptide and arterial stiffness in healthy Japanese men. Am J Hypertens. 2006;19:443–447
  37. Watanabe S, Shite J, Takaoka H, Shinke T, Imuro Y, Ozawa T, et al. Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure. Eur Heart J. 2006;27:832–838

 Drs Enache, B. A. Popescu, and A. C. Popescu were supported by research fellowships from the Association for Research in Cardiology (Pordenone, Italy).

PII: S0894-7317(09)00760-3

doi: 10.1016/j.echo.2009.08.009

Journal of the American Society of Echocardiography
Volume 22, Issue 11 , Pages 1239-1245 , November 2009

Article Tools

* Image Usage & Resolution